Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
... (pegloticase) as a treatment for chronic
gout in patients refractory to conventional therapy. ... so we can provide this therapy to those chronic
gout patients who are suffering from this crippling, ... enzyme intended for the treatment of chronic
gout in patients refractory to conventional therapy. ...
The Gout & Uric Acid Education Society (GUAES) Announces New Survey Results Highlighting Major Gaps in Public Awareness of Gout
... New Findings Released on the Third Annual
gout Awareness Day (May 22)
NEW YORK, May 22 /PRNewswire/ -- The
gout & Uric Acid Education Society announced today ... to being "not at all knowledgeable" about
gout and just over 70% did not know ...
More Vitamin C May Mean Less Chance of Gout
... was less than 250 milligrams a day, the risk for
gout was 17 percent lower among men with a daily ... 500 mg increase in vitamin C intake, the risk for
gout fell 17 percent, the researchers calculated.
... milligrams a day had a 34 percent lower risk of
gout than men who did not take vitamin C supplements. ...
FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout
... patients who have hyperuricemia associated with
gout a new treatment option that helps prevent uric ... doctor during a flare not understanding that
gout is a chronic disease that needs to be managed on ... recognize that a goal in the treatment of chronic
gout is the reduction and maintenance of serum uric ...
Pegloticase BLA Filing Accepted for Priority Review by FDA
... Application for Treatment-Failure
gout Granted Priority Review
EAST BRUNSWICK, ... a novel biological drug for treatment-failure
gout (TFG) patients. The FDA also granted the ... designation by the FDA.
Treatment-failure
gout occurs in patients who have failed to normalize ...
Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
... of therapy available to the treatment-failure
gout population and we believe the work of this ... major improvement in the treatment of this orphan
gout population. I look forward to working with the ... absence of other therapies for treatment-failure
gout patients, are forward-looking statements. These ...
Studies examine treatment for gout and the condition's protective effects
... The goal in treating patients with
gout is to reduce acute attacks by lowering serum ... of febuxostat, a new drug being developed for
gout that was recently approved for use in Europe, and ... years. Another study examined the link between
gout and PD in individuals 65 years and older. The ...
New Drug Helps Relieve Gout
... Sept. 3 (HealthDay News) -- An experimental
gout drug called pegloticase lowered levels of uric ... treatment, 88 percent of the patients experienced
gout flares and some also experienced mild to moderate ... Academy of Family Physicians has more about
gout .
-- Robert ...
Basketball Star Details His Struggle With Gout
...
And he's got gout.
"I had no idea what
gout was," Cheeks said, describing his first encounter ... New York City to mark the second annual National
gout Awareness Day, sponsored by the
gout & Uric Acid Education Society (GUAES). The ...
NBA Coach Maurice Cheeks Teams Up with the Gout & Uric Acid Education Society (GUAES) to Call a 'Time Out for Gout'
... Cheeks partners with rheumatology experts on
gout Awareness Day to share his story and correct ... All-Star Maurice Cheeks is partnering with the
gout & Uric
Acid Education Society (GUAES) to spread the word about
gout -- a common
and intensely painful form of ...
More>>
gout in Medical Technology
Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
... the management of hyperuricemia associated with
gout in more than 40 years.
The FDA will ... and symptoms, and diarrhea.
About
gout and Uric Acid
Uric acid is an ... greater the risk for developing gout.
gout is the most common inflammatory arthritis in men ...
Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
... organization, and the
importance we place on our
gout program -- a program we intend to expand
with ... flares), and kidney damage (nephropathy).
While
gout is a treatable condition, there are limited ... the treatment of
hyperuricemia associated with
gout in the past 40 years
About RDEA594
RDEA594, ...
Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
... for the treatment of patients with gout, RDEA594.
gout is a
painful and debilitating disease that is ... flares), and kidney
damage (nephropathy). While
gout is a treatable condition, there are
limited ... treatment of hyperuricemia associated with
gout in the past 40 years.
About RDEA594
RDEA594 ...
Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
... 1 Clinical Study
- Phase 2 Efficacy Study in
gout Patients to Start in the First Half of ... Drug Administration for the underlying cause of
gout in the past 40
years, there is a significant need ... Phase 2, dose-ranging clinical
efficacy study in
gout patients with hyperuricemia in the first half ...
New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
... is indicated for the chronic management of hyperuricemia associated with
gout and represents the first product for
gout that has been approved in over forty years.
LaunchTrends(TM): ...
Savient Provides Update on Pegloticase BLA
... Patients in the every 2 week dose regimen have demonstrated statistically significant clinical improvements including the reduction and resolution of
gout tophi. Other statistically and clinically meaningful improvements included decreases in tender or swollen joint counts, reduction in flare ...
Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
... -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that its biologics license application (BLA) for pegloticase for treatment-failure
gout will be reviewed by the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) on March 5, 2009 as required for a drug ...
September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging
... if a kidney stone is made of uric
acid or if it contains calcium. Uric acid stones can be treated with
medication, avoiding surgery.
-- Detecting
gout -- A dual energy X-ray image shows the presence and
location of gout. Standard X-rays, even combined with a needle biopsy,
don't always provide the ...
Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
... elevated urate levels are known to carry certain health
risks, only some of which have been definitively characterized to date.
Kidney stones and
gout are known risks; cardiovascular disease is a
possible risk. (In the clinical trial, safety measures will be in place to
help avoid these conditions, ...
gout in Medical Dictionary
Arthritis
... l tissue within joints . Arthritis ,
gout : Joint inflammation caused by uric acid ... . Arthritis "1 Arthritis "2; Rheumatoid
gout [Kellogg] Rheumatoid Arthritis "1 Articular ... [Kellogg] Chronic Rheumatism [Kellogg]
gout "1 ...
Gout
...
gout Overview
gout is a condition in which the body has a problem in the handling of uric acid . People with
gout either produce too much uric acid or more ...
Hyperuricemia
... Hyperuricemia does not inevitably lead to
gout . In fact, less than 20% of the hyperuricemic ... of uric acid in the blood , often producing
gout . PurineA white crystalline substance that is one ... , hyperkalemia , and hyperphosphatemia.
gout is caused by too much uric acid in the blood ...
Joint
... S " Arthritis "1 Arthritis "2; Rheumatoid
gout [Kellogg] Rheumatoid Arthritis "1 Articular ... [Kellogg] Chronic Rheumatism [Kellogg]
gout "1
gout "2 [Kellogg] Bursitis ... joint The ...
Joints
... " Arthritis "1 Arthritis "2; Rheumatoid
gout [Kellogg] Rheumatoid Arthritis "1 Articular ... [Kellogg] Chronic Rheumatism [Kellogg]
gout "1
gout "2 [Kellogg] Bursitis ... Joints are the ...
Knee
... -- including rheumatoid , osteoarthritis , and
gout , or other connective tissue disorders like ... with your opposite hand . The symptoms of
gout --severe pain , usually in the hand or foot ... with your knee bent at a 30 degree angle.
gout usually begins with an acute attack of pain , ...
Pseudogout
... Pseudogout is so named for its similarity to
gout . Like
gout , pseudogout causes sudden, severe pain in a ... recurrent arthritis clinically similar to
gout ; features include calcification of cartilage ....
Psoriatic arthritis
... numbers of white blood cells may indicate
gout , pseudogout , inflammatory forms of arthritis ... Uric acid crystals in the joint indicate
gout . most common forms are osteoarthritis (this article), rheumatoid arthritis (which see),
gout (which see), and ankylosing spondylitis (which ...
Uric acid
... of purines that are part of many foods . In
gout , there are frequently, but not always, elevated ... of attacks is usually reduced dramatically.
gout is caused by uric acid crystals forming in the ... p-aminohipp uric acid ; ... Alcohol can cause
gout because it can keep your body from getting rid ...
Ankylosing spondylitis
... attack about 1. Examples of other forms of arthritis include
gout , ankylosing spondylitis , and arthritis that occurs after an injury ... arthritis , ankylosing spondylitis , psoriatic arthritis , lupus ,
gout , pseudogout ). However, it also can be related to poorly fitting ...
More>>
gout in Biological News
New player in commitment to life as a fat cell
... byproduct uric acid, XOR had earlier been implicated in gout, said Jeffrey Friedman of The Rockefeller University, senior author of the study.
gout is a painful type of arthritis that results when uric acid crystals build up in the joints.
"These findings are novel in many aspects," said ...
Viagra's hidden help for wildlife
... large TCM clinic in Hong Kong. The men were questioned about their previous and current use of TCM and Western treatments for arthritis, indigestion,
gout and impotence.
The study's lead authors are Dr Bill von Hippel, a psychologist from the University of New South Wales (Sydney, Australia), and his ...
gout in Biological Technology
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout
... of refractory chronic gout. Refractory chronic
gout or treatment failure
gout (TFG) is
gout in patients who have failed to normalize serum ...
Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
... disability in patients with treatment failure
gout appeared in the Journal of Rheumatology.
... the disabling aspects of the treatment failure
gout population."
Financial Results of ... KRYSTEXXA(TM) (pegloticase) for treatment failure
gout has reported positive Phase 1, 2 and 3 clinical ...
Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients
... of Life and Disability in Treatment Failure
gout Patients
EAST BRUNSWICK, N.J., May 5 ... study of patients with treatment failure
gout (TFG). The objective of the study was to ... of life in patients with treatment failure
gout and appears in the May issue of the Journal of ...
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
... patients who have hyperuricemia associated with
gout a new treatment option that helps prevent uric ... doctor during a flare not understanding that
gout is a chronic disease that needs to be managed on ... recognize that a goal in the treatment of chronic
gout is the reduction and maintenance of serum uric ...
Savient's Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
... pivotal clinical studies in treatment-failure
gout (TFG)
patients was presented at scientific ... that included the effect of pegloticase on
gout tophi, gout
flares, and the immune response to ... of their signs and symptoms of
treatment-failure
gout with continuing pegloticase treatment, extending ...
Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
... in men over 40. The Company also announced that
gout specialist,
Dr. Fernando Perez-Ruiz in Spain, ... in
the target population of patients with
gout using its prodrug, RDEA806.
Enrollment in the ... League
Against Rheumatism (EULAR) Task Force for
gout and with the Outcome
Measures for Rheumatic ...
The Law Offices of Brian D. Witzer Wins 6+ Million Dollar Verdict
... that she did not have gout. The doctor claimed that she told him she had
gout and described pain in her toe consistent with gout. He prescribed Allopurinol in order to prevent a recurrence of an acute
gout attack. Plaintiff made a statutory offer to compromise the claim in ...
Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout
... (TM) (pegloticase), a novel biological drug for treatment failure
gout (TFG) patients, will be reviewed by the Arthritis Advisory Committee ... development candidate, KRYSTEXXA(TM) (pegloticase) for treatment failure
gout has reported positive Phase 1, 2 and 3 clinical data. The KRYSTEXXA Phase ...
Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
... Arthritis - - RDEA594 Shows Promise as an Effective Treatment for
gout -
SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Ardea Biosciences, ... Biosciences' President and CEO. "In
addition, we are on track to begin two
gout trials, a Phase 1 trial with
RDEA594 in the second half of this year and a ...
Savient Submits Biologics License Application (BLA) for pegloticase
... President and Chief Executive Officer. "This filing
reflects our commitment to changing the paradigm of therapy available to
the treatment-failure
gout population and brings us one step closer to
commercializing this drug and offering a solution to patients who suffer
from this debilitating ...
gout in Biological Definition
Colchicine
... to treat rheumatic complaints and especially
gout , it was also prescribed for its cathartic and ... extract was first described as a treatment for
gout in De Materia Medica of Padanius Dioscorides ... pain relieving and anti-inflammatory effects for
gout were linked to it binding with the protein ...
Purine
... tissue turnover) are metabolized by several enzymes , including xanthine oxidase , into uric acid . High levels of uric acid can predispose to
gout when the acid crystalizes in joints; this phenomenon only happens in humans and some animal species (e.g. dogs) that lack an intrinsic urease ...
Tubulin
... play a role in forming the mitotic spindle during mitosis.
Pharmacology
Tubulins are targets for anticancer drugs like taxol . The anti-
gout agent colchicine binds to tubulin and inhibits microtubule formation, arresting neutrophil motility and decreasing inflammation .
...
gout in Biological Dictionary
Uric acid
... amount of uric acid in a blood sample. ... If
gout remains untreated, these uric acid crystals ... can crystallize to form ... uric acid
gout food high in uric acid level danger and side ... Video of Uric Acid / Tophi Deposits caused by
gout Attacks in Dissected Big Toe. ... Sometimes uric ...
Purine
... into serum uric acid (which is can cause
gout when ... Purine rich foods are on the top of ... ... Diet is not the only solution for reducing
gout attacks, but avoiding purine -rich foods is recommended. ... a person with
gout should avoid purine -rich foods. ... What ...
Colchicine
... is used to prevent or treat attacks of
gout (also ... Colchicine does not cure
gout or take the ... Physician reviewed colchicine ... Colchicine has long been used to relieve acute
gout attacks. ... Colchicine may be an option for ...